1.29
price down icon3.01%   -0.04
after-market Handel nachbörslich: 1.28 -0.01 -0.78%
loading
Schlusskurs vom Vortag:
$1.33
Offen:
$1.28
24-Stunden-Volumen:
1.19M
Relative Volume:
0.63
Marktkapitalisierung:
$91.73M
Einnahmen:
$391.70K
Nettoeinkommen (Verlust:
$-52.34M
KGV:
-1.72
EPS:
-0.75
Netto-Cashflow:
$-45.92M
1W Leistung:
+3.20%
1M Leistung:
+159.82%
6M Leistung:
+152.94%
1J Leistung:
+18.35%
1-Tages-Spanne:
Value
$1.27
$1.34
1-Wochen-Bereich:
Value
$1.16
$1.34
52-Wochen-Spanne:
Value
$0.2425
$1.47

Ovid Therapeutics Inc Stock (OVID) Company Profile

Name
Firmenname
Ovid Therapeutics Inc
Name
Telefon
212-776-4381
Name
Adresse
441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY
Name
Mitarbeiter
23
Name
Twitter
@OvidRx
Name
Nächster Verdiensttermin
2024-11-04
Name
Neueste SEC-Einreichungen
Name
OVID's Discussions on Twitter

Vergleichen Sie OVID mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
OVID
Ovid Therapeutics Inc
1.29 87.46M 391.70K -52.34M -45.92M -0.75
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Ovid Therapeutics Inc Stock (OVID) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-08-08 Fortgesetzt B. Riley Securities Buy
2024-06-18 Herabstufung Oppenheimer Outperform → Perform
2024-04-30 Eingeleitet B. Riley Securities Buy
2024-04-29 Eingeleitet H.C. Wainwright Buy
2024-04-05 Eingeleitet Wedbush Outperform
2023-12-21 Eingeleitet BTIG Research Buy
2023-10-13 Eingeleitet Oppenheimer Outperform
2021-04-20 Herabstufung Cantor Fitzgerald Buy → Neutral
2021-03-03 Herabstufung RBC Capital Mkts Outperform → Sector Perform
2020-12-02 Herabstufung Citigroup Buy → Neutral
2020-12-02 Herabstufung JMP Securities Mkt Outperform → Mkt Perform
2019-09-04 Eingeleitet RBC Capital Mkts Outperform
2018-04-20 Eingeleitet Ladenburg Thalmann Buy
Alle ansehen

Ovid Therapeutics Inc Aktie (OVID) Neueste Nachrichten

pulisher
Sep 04, 2025

Smart tools for monitoring Ovid Therapeutics Inc.’s price actionOptions Play & Real-Time Volume Spike Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can swing trading help recover from Ovid Therapeutics Inc. lossesWeekly Profit Report & Safe Entry Point Identification - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Using Ichimoku Cloud for Ovid Therapeutics Inc. technicalsPortfolio Growth Summary & Accurate Buy Signal Notifications - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How to track smart money flows in Ovid Therapeutics Inc.Quarterly Market Review & Smart Allocation Stock Tips - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Why is Ovid Therapeutics Inc. stock going upChart Signals & Community Consensus Trade Alerts - khodrobank.com

Sep 04, 2025
pulisher
Sep 04, 2025

Custom watchlist performance reports with Ovid Therapeutics Inc.Stock Surge & AI Driven Price Predictions - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Building trade automation scripts for Ovid Therapeutics Inc.July 2025 Review & High Conviction Investment Ideas - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

What hedge funds are buying Ovid Therapeutics Inc.Weekly Profit Summary & High Accuracy Investment Signals - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Multi asset correlation models including Ovid Therapeutics Inc.Profit Target & AI Based Trade Execution Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Visualizing Ovid Therapeutics Inc. stock with heatmapsJuly 2025 Final Week & Pattern Based Trade Signal System - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What indicators show strength in Ovid Therapeutics Inc.July 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Real time social sentiment graph for Ovid Therapeutics Inc.Trade Risk Assessment & Low Drawdown Investment Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Ovid Therapeutics Inc. forming a bottoming base2025 Short Interest & Reliable Momentum Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What MACD signals say about Ovid Therapeutics Inc.Product Launch & Safe Entry Point Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Using Bollinger Bands to evaluate Ovid Therapeutics Inc.2025 Big Picture & Free High Return Stock Watch Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Full technical analysis of Ovid Therapeutics Inc. stockJuly 2025 Patterns & Precise Swing Trade Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

What recovery options are there for Ovid Therapeutics Inc.Sell Signal & Weekly Return Optimization Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Multi factor analysis applied to Ovid Therapeutics Inc.Market Risk Analysis & Stock Portfolio Risk Management - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Key resistance and support levels for Ovid Therapeutics Inc.2025 Trading Recap & Low Risk High Reward Ideas - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Ovid Therapeutics Reports Increased Revenue Amid Challenges - MSN

Sep 02, 2025
pulisher
Sep 02, 2025

Investment Review: Is Ovid Therapeutics Inc. forming a breakout patternJuly 2025 Update & Free Risk Controlled Daily Trade Plans - khodrobank.com

Sep 02, 2025
pulisher
Sep 02, 2025

How hedge fund analytics apply to Ovid Therapeutics Inc. stockSwing Trade & Community Verified Trade Alerts - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Is Ovid Therapeutics Inc. subject to activist investor interestJuly 2025 Drop Watch & Safe Investment Capital Preservation Plans - khodrobank.com

Sep 01, 2025
pulisher
Sep 01, 2025

Is it too late to sell Ovid Therapeutics Inc.Weekly Trading Summary & Stock Portfolio Risk Management - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Ovid Therapeutics Inc. stock volume spike explainedTrade Risk Summary & Daily Stock Trend Watchlist - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Analyzing Ovid Therapeutics Inc. with multi timeframe chartsWeekly Profit Analysis & AI Forecasted Stock Moves - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Does Ovid Therapeutics Inc. fit your quant trading modelWeekly Loss Report & Fast Moving Trade Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Quantitative breakdown of Ovid Therapeutics Inc. recent moveRate Cut & Weekly High Potential Stock Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Ovid Therapeutics Inc. recovery potential after sell offTrade Exit Summary & Weekly High Return Forecasts - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Traders Consider Averaging Down in Ovid Therapeutics Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스

Aug 30, 2025
pulisher
Aug 30, 2025

What machine learning models say about Ovid Therapeutics Inc.Weekly Trade Summary & Real-Time Sentiment Analysis - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Using R and stats models for Ovid Therapeutics Inc. forecastingMarket Risk Analysis & Real-Time Stock Entry Alerts - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Ovid Therapeutics Inc. Company Revenue and Profit Trends: A Deep Dive2025 Historical Comparison & AI Driven Stock Movement Reports - Newser

Aug 30, 2025

Finanzdaten der Ovid Therapeutics Inc-Aktie (OVID)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading

Ovid Therapeutics Inc-Aktie (OVID) Insiderhandel

Insiderhandel Beziehung Datum Transaktion Kosten #Aktien Wert ($) #Aktien Gesamt
Rona Jeffrey A
CBFO
Feb 26 '25
Sale
0.56
3,902
2,185
67,973
ALEXANDER MARGARET A.
President and COO
Jan 27 '25
Buy
0.73
6,810
4,971
34,935
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):